332 related articles for article (PubMed ID: 8685268)
1. Inhibitors of serine/threonine phosphoprotein phosphatases alter circadian properties in Gonyaulax polyedra.
Comolli J; Taylor W; Rehman J; Hastings JW
Plant Physiol; 1996 May; 111(1):285-91. PubMed ID: 8685268
[TBL] [Abstract][Full Text] [Related]
2. The involvement of protein phosphatases in the activation of ICE/CED-3 protease, intracellular acidification, DNA digestion, and apoptosis.
Morana SJ; Wolf CM; Li J; Reynolds JE; Brown MK; Eastman A
J Biol Chem; 1996 Jul; 271(30):18263-71. PubMed ID: 8663484
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of protein phosphatase 1 stimulates secretion of Alzheimer amyloid precursor protein.
da Cruz e Silva EF; da Cruz e Silva OA; Zaia CT; Greengard P
Mol Med; 1995 Jul; 1(5):535-41. PubMed ID: 8529119
[TBL] [Abstract][Full Text] [Related]
4. Effects of serine/threonine protein phosphatase inhibitors on morphine-induced antinociception in the tail flick test in mice.
Moncada A; Cendán CM; Baeyens JM; Del Pozo E
Eur J Pharmacol; 2003 Mar; 465(1-2):53-60. PubMed ID: 12650833
[TBL] [Abstract][Full Text] [Related]
5. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.
Honkanen RE
FEBS Lett; 1993 Sep; 330(3):283-6. PubMed ID: 8397101
[TBL] [Abstract][Full Text] [Related]
6. Activation of sodium transport in rat erythrocytes by inhibition of protein phosphatases 1 and 2A.
Ivanova TI; Agalakova NI; Gusev GP
Comp Biochem Physiol B Biochem Mol Biol; 2006 Sep; 145(1):60-7. PubMed ID: 16875859
[TBL] [Abstract][Full Text] [Related]
7. T cell apoptosis induced by interleukin-2 deprivation or transforming growth factor-beta 2: modulation by the phosphatase inhibitors okadaic acid and calyculin A.
Weller M; Malipiero U; Groscurth P; Fontana A
Exp Cell Res; 1995 Dec; 221(2):395-403. PubMed ID: 7493639
[TBL] [Abstract][Full Text] [Related]
8. Contrasting effects of calyculin A and okadaic acid on the respiratory burst of human neutrophils.
Djerdjouri B; Combadière C; Pedruzzi E; Hakim J; Périanin A
Eur J Pharmacol; 1995 Jan; 288(2):193-200. PubMed ID: 7720781
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.
Resjö S; Oknianska A; Zolnierowicz S; Manganiello V; Degerman E
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 1 and 2A inhibitors activate acyl-CoA:cholesterol acyltransferase and cholesterol ester formation in isolated rat hepatocytes.
Hernández ML; Martínez MJ; López de Heredia M; Ochoa B
Biochim Biophys Acta; 1997 Nov; 1349(3):233-41. PubMed ID: 9434137
[TBL] [Abstract][Full Text] [Related]
11. Okadaic acid indicates a major function for protein phosphatases in stimulus-response coupling of RINm5F rat insulinoma cells.
Mayer P; Jochum C; Schatz H; Pfeiffer A
Exp Clin Endocrinol; 1994; 102(4):313-9. PubMed ID: 7813603
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of an archaeal protein phosphatase activity by okadaic acid, microcystin-LR, or calyculin A.
Oxenrider KA; Rasche ME; Thorsteinsson MV; Kennelly PJ
FEBS Lett; 1993 Oct; 331(3):291-5. PubMed ID: 8397116
[TBL] [Abstract][Full Text] [Related]
13. Hyperphosphorylation of beta-catenin on serine-threonine residues and loss of cell-cell contacts induced by calyculin A and okadaic acid in human epidermal cells.
Serres M; Grangeasse C; Haftek M; Durocher Y; Duclos B; Schmitt D
Exp Cell Res; 1997 Feb; 231(1):163-72. PubMed ID: 9056423
[TBL] [Abstract][Full Text] [Related]
14. The effects of okadaic acid and calyculin A on thrombin induced platelet reaction.
Murata K; Sakon M; Kambayashi J; Yukawa M; Ariyoshi H; Shiba E; Kawasaki T; Kang J; Mori T
Biochem Int; 1992 Feb; 26(2):327-34. PubMed ID: 1313673
[TBL] [Abstract][Full Text] [Related]
15. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity.
Ishihara H; Martin BL; Brautigan DL; Karaki H; Ozaki H; Kato Y; Fusetani N; Watabe S; Hashimoto K; Uemura D
Biochem Biophys Res Commun; 1989 Mar; 159(3):871-7. PubMed ID: 2539153
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of protein phosphatase type 1 and 2A attenuate phosphatidylinositol metabolism and Ca(2+)-transients in human platelets. Role of a cdc2-related protein kinase.
Lerea KM
Biochemistry; 1992 Jul; 31(28):6553-61. PubMed ID: 1321663
[TBL] [Abstract][Full Text] [Related]
17. The protein phosphatase inhibitor calyculin A stimulates chemokine production by human synovial cells.
Jordan NJ; Watson ML; Westwick J
Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):89-95. PubMed ID: 7575485
[TBL] [Abstract][Full Text] [Related]
18. Role of phosphoprotein phosphatases in the corpus luteum: I identification and characterisation of serine/threonine phosphoprotein phosphatases in isolated rat luteal cells.
Ford SL; Abayasekara DR; Persaud SJ; Jones PM
J Endocrinol; 1996 Aug; 150(2):205-11. PubMed ID: 8869587
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase inhibitors induce the sustained expression of the Egr-1 gene and the hyperphosphorylation of its gene product.
Cao X; Mahendran R; Guy GR; Tan YH
J Biol Chem; 1992 Jun; 267(18):12991-7. PubMed ID: 1320009
[TBL] [Abstract][Full Text] [Related]
20. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity.
Suganuma M; Fujiki H; Okabe S; Nishiwaki S; Brautigan D; Ingebritsen TS; Rosner MR
Toxicon; 1992 Aug; 30(8):873-8. PubMed ID: 1326138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
